Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 24, Issue 1, 2019, Pages 70-77

  Nana Leventaki, E ^a   Nana, M ^a   Poulianitis, N ^b   Sampaziotis, D ^b   Perrea, D ^a   Sanoudou, D ^a,c   Rontogianni, D ^b   Malliaras, K ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

cardiosphere derived cells; cell therapy; experimental autoimmune myocarditis; giant cell myocarditis; myocarditis

Indexed keywords

CARDIAC MYOSIN; MYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC ROOT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; CARDIAC MUSCLE CELL; CARDIOSPHERE DERIVED CELL; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART VOLUME; HISTOLOGY; INFLAMMATION; LEWIS RAT; LYMPHOCYTIC INFILTRATION; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE; T LYMPHOCYTE; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; DISEASE MODEL; FIBROSIS; HEART LEFT VENTRICLE FUNCTION; IMMUNOLOGY; MULTICELLULAR SPHEROID; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; AUTOIMMUNE DISEASES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; MYOCARDITIS; MYOCARDIUM; MYOSINS; RATS, INBRED LEW; SPHEROIDS, CELLULAR; STEM CELL TRANSPLANTATION; SYSTOLE; T-LYMPHOCYTES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 85052227990     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248418784287     Document Type: Article

References (40)

1. Kindermann I, Barth C, Mahfoud F. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779–792
2. Heymans S, Eriksson U, Lehtonen J, Cooper LT, Jr. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol. 2016;68(21):2348–2364
3. Smith RR, Barile L, Cho HC. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7):896–908
4. Makkar RR, Smith RR, Cheng K. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895–904
5. Malliaras K, Makkar RR, Smith RR. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014;63(2):110–122
6. Chakravarty T, Makkar R, Henry T. TCT-820 multivessel intracoronary infusion of allogeneic cardiosphere derived cells in dilated cardiomyopathy: long term outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial). J Am Coll Cardiol. 2016; 68:B332 (abstract)
7. Ishigami S, Ohtsuki S, Eitoku T. Intracoronary cardiac progenitor cells in single ventricle physiology: the PERSEUS (cardiac progenitor cell infusion to treat univentricular heart disease) randomized phase 2 trial. Circ Res. 2017;120(7):1162–1173
8. Ishigami S, Ohtsuki S, Tarui S. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2017;116(4):653–664
9. Malliaras K, Zhang Y, Seinfeld J. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med. 2013;5(2):191–209
10. Malliaras K, Ibrahim A, Tseliou E. Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med. 2014;6(6):760–777
11. Weil BR, Suzuki G, Leiker MM, Fallavollita JA, Canty JM. Comparative efficacy of intracoronary allogeneic mesenchymal stem cells and cardiosphere-derived cells in swine with hibernating myocardium. Circ Res. 2015;117(7):634–644
12. Suzuki G, Weil BR, Leiker MM. Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium. PLoS One. 2014;9(11):e113009
13. Malliaras K, Smith RR, Kanazawa H. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013;128(25):2764–2775
14. Kanazawa H, Tseliou E, Malliaras K. Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circ Heart Fail. 2015;8(2):322–332
15. de Couto G, Liu W, Tseliou E. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest. 2015;125(8):3147–3162
16. Tseliou E, Pollan S, Malliaras K. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. J Am Coll Cardiol. 2013;61(10):1108–1119
17. Lauden L, Boukouaci W, Borlado LR. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. Circ Res. 2013;112(3):451–464
18. Boukouaci W, Lauden L, Siewiera J. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res. 2014;104(2):290–302
19. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990;57(2):250–262
20. Kodama M, Hanawa H, Saeki M. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75(2):278–284
21. Ishikane S, Yamahara K, Sada M. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J Mol Cell Cardiol. 2010;49(5):753–761
22. Cooper LT, Jr. Giant cell myocarditis: diagnosis and treatment. Herz. 2000;25(3):291–298
23. Schmerler P, Jeuthe S, Oh Ici D. Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats. Acta Physiol (Oxf). 2014;210(4):889–898
24. Malliaras K, Li TS, Luthringer D. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation. 2012;125(1):100–112
25. Cheng K, Malliaras K, Li TS. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 2012;21(6):1121–1135
26. Li Q, Guo Y, Ou Q. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011;106(5):849–864
27. Afanasyeva M, Georgakopoulos D, Rose NR. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev. 2004;3(7-8):476–486
28. Grün S, Schumm J, Greulich S. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604–1615
29. Li TS, Cheng K, Malliaras K. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol. 2012;59(10):942–953
30. Takehara N, Tutsumi Y, Tateishi K. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008;52(23):1858–1865
31. Ohnishi S, Yanagawa B, Tanaka K. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol. 2007;42(1):88–97
32. Ohshima M, Yamahara K, Ishikane S. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. J Mol Cell Cardiol. 2012;53(3):420–428
33. Carmona MD, Cañadillas S, Romero M, Blanco A, Nogueras S, Herrera C. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy. Cytotherapy. 2017;19(8):947–961
34. Okada H, Suzuki J, Futamatsu H, Maejima Y, Hirao K, Isobe M. Attenuation of autoimmune myocarditis in rats by mesenchymal stem cell transplantation through enhanced expression of hepatocyte growth factor. Int Heart J. 2007;48(5):649–661
35. Tseliou E, Kanazawa H, Dawkins J. Widespread myocardial delivery of heart-derived stem cells by nonocclusive triple-vessel intracoronary infusion in porcine ischemic cardiomyopathy: superior attenuation of adverse remodeling documented by magnetic resonance imaging and histology. PLoS One. 2016;11(1):e0144523
36. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. 2001;16(3):175–186
37. Yuan Z, Shioji K, Kishimoto C. Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis. Exp Clin Cardiol. 2003;8(1):13–16
38. Bu DX, Tarrio M, Maganto-Garcia E. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):1100-1107
39. Kim KS, Denton MD, Chandraker A. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7 -1 in initiation versus progression of graft arteriosclerosis. Am J Pathol. 2001;158:977-986.]
40. Tarrio ML, Grabie N, Bu DX, Sharpe AH, Lichtman AH. PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. J Immunol. 2012;188(10):4876–4884